Compare TTEK & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEK | CAI |
|---|---|---|
| Founded | 1966 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 6.0B |
| IPO Year | 1995 | N/A |
| Metric | TTEK | CAI |
|---|---|---|
| Price | $33.70 | $18.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $44.00 | $33.67 |
| AVG Volume (30 Days) | ★ 3.1M | 2.0M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $2,964,148,000.00 | N/A |
| Revenue This Year | N/A | $24.26 |
| Revenue Next Year | $6.53 | $22.60 |
| P/E Ratio | $87.04 | ★ N/A |
| Revenue Growth | ★ 7.66 | N/A |
| 52 Week Low | $27.27 | $17.15 |
| 52 Week High | $43.14 | $42.50 |
| Indicator | TTEK | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.62 | 36.87 |
| Support Level | $32.37 | $17.15 |
| Resistance Level | $35.96 | $21.47 |
| Average True Range (ATR) | 1.32 | 1.27 |
| MACD | -0.18 | 0.13 |
| Stochastic Oscillator | 28.78 | 31.13 |
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.